Profitability
by Company within Major Pharmaceutical Preparations Industry
|
| Company |
Quarter |
Gross Margin |
Net Margin |
Cash flow Margin |
ROE |
| Aadi Bioscience Inc |
2 Q |
89.42% |
-289.76% |
- |
-40.72% |
| Abbvie Inc |
2 Q |
69.42% |
14.62% |
14.77% |
58.42% |
| Abcellera Biologics Inc |
2 Q |
- |
-303.58% |
-131.97% |
-6.05% |
| Abeona Therapeutics Inc |
2 Q |
- |
-425.17% |
39.44% |
-207.07% |
| American Bio Medica Corporation |
1 Q |
45.12% |
- |
20.73% |
- |
| Abbott Laboratories |
2 Q |
55.07% |
13.78% |
-13.29% |
14% |
| Arbutus Biopharma Corp |
2 Q |
- |
-367.53% |
-287.62% |
-5.65% |
| Abvc Biopharma Inc |
2 Q |
-1094.65% |
-37898.59% |
-17182.66% |
-485.19% |
| Acadia Pharmaceuticals Inc |
2 Q |
95.49% |
0.67% |
-109.3% |
-27.77% |
| Acer Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Adicet Bio Inc |
2 Q |
- |
- |
- |
-41.3% |
| Ac Immune Sa |
4 Q |
- |
- |
- |
-31.47% |
| Aclaris Therapeutics Inc |
2 Q |
44.25% |
-1582.08% |
-726.16% |
-54.43% |
| Acrivon Therapeutics Inc |
2 Q |
- |
- |
- |
-24.55% |
| Acelrx Pharmaceuticals Inc |
2 Q |
- |
-1727.67% |
-2349.01% |
-173.66% |
| Acasti Pharma Inc |
2 Q |
- |
- |
- |
-51% |
| Acura Pharmaceuticals inc |
4 Q |
- |
80.56% |
-66.67% |
- |
| Accustem Sciences Inc |
2 Q |
- |
- |
- |
- |
| Acurx Pharmaceuticals inc |
2 Q |
- |
- |
- |
-183.88% |
| Adc Therapeutics Sa |
4 Q |
95.89% |
-678.2% |
- |
-138.5% |
| Adial Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-231.92% |
| Adamis Pharmaceuticals Corporation |
2 Q |
-5103.66% |
-123457.48% |
-34981.9% |
- |
| Adamas Pharmaceuticals Inc |
3 Q |
97.78% |
-75.37% |
-39.29% |
- |
| Aditxt Inc |
2 Q |
15.95% |
-2571.3% |
-93.47% |
-775.4% |
| Addex Therapeutics Ltd |
4 Q |
- |
-1462.57% |
- |
-312.48% |
| Ayala Pharmaceuticals Inc |
2 Q |
0% |
-96655.56% |
-108511.11% |
-176.71% |
| Aeterna Zentaris Inc |
4 Q |
97.22% |
-402.96% |
- |
-15.79% |
| Kaya Holdings Inc |
2 Q |
64.23% |
-1295.73% |
- |
- |
| Affimed N v |
4 Q |
- |
-207.98% |
- |
-37.62% |
| Agex Therapeutics Inc |
2 Q |
44.44% |
-29766.67% |
- |
- |
| Agios Pharmaceuticals Inc |
2 Q |
83.49% |
-1248.6% |
-288.83% |
-20.24% |
| Aeglea Biotherapeutics Inc |
2 Q |
- |
-31552.47% |
- |
- |
| Agile Therapeutics Inc |
2 Q |
61.51% |
-73.31% |
-31.64% |
- |
| Ainos Inc |
2 Q |
-95.47% |
-8228.78% |
- |
-44.32% |
| Akebia Therapeutics Inc |
4 Q |
- |
-16.74% |
-99.31% |
-350.61% |
| Akero Therapeutics Inc |
2 Q |
- |
- |
- |
-29.01% |
| Akari Therapeutics Plc |
4 Q |
- |
- |
- |
-991.1% |
| Akouos inc |
3 Q |
- |
- |
- |
-45.09% |
| Albireo Pharma inc |
3 Q |
93.78% |
-384.46% |
- |
-97.59% |
| Aldeyra Therapeutics Inc |
2 Q |
- |
- |
- |
-35.88% |
| Alimera Sciences Inc |
2 Q |
88.31% |
-58.6% |
33.25% |
- |
| Alkermes Plc |
2 Q |
89.75% |
38.4% |
55.78% |
9.42% |
| Allakos Inc |
2 Q |
- |
- |
- |
-50.87% |
| Allarity Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Alnylam Pharmaceuticals Inc |
2 Q |
76.37% |
-86.59% |
-4.53% |
- |
| Alpine Immune Sciences Inc |
2 Q |
- |
-153.1% |
- |
-33.45% |
| Aileron Therapeutics Inc |
2 Q |
- |
- |
- |
-102.25% |
| Altimmune inc |
2 Q |
- |
-267683.33% |
-38850% |
-44.81% |
| Alexion Pharmaceuticals Inc |
1 Q |
92.34% |
29.89% |
28.84% |
4.69% |
| Alx Oncology Holdings Inc |
2 Q |
- |
- |
- |
-51.97% |
| Alzamend Neuro Inc |
2 Q |
- |
- |
- |
-349.7% |
| Amylyx Pharmaceuticals Inc |
2 Q |
94.32% |
22.47% |
- |
-23.8% |
| Ampio Pharmaceuticals inc |
2 Q |
- |
- |
- |
-139.53% |
| Amphastar Pharmaceuticals Inc |
2 Q |
49.92% |
17.93% |
-17.55% |
18.78% |
| Amarin Corp Plcuk |
2 Q |
53.22% |
-21.9% |
51.87% |
-6.56% |
| Amneal Pharmaceuticals Inc |
2 Q |
36.23% |
-43.37% |
-21.38% |
-82.1% |
| Applied Molecular Transport Inc |
2 Q |
- |
- |
- |
-189.89% |
| Amryt Pharma Plc |
4 Q |
52.32% |
0% |
53.38% |
0% |
| Anaptysbio inc |
2 Q |
- |
-1151.59% |
-1715.49% |
-65.52% |
| Anebulo Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-73.81% |
| Angion Biomedica Corp |
2 Q |
- |
-1399.54% |
-1474.73% |
-35.45% |
| Ani Pharmaceuticals Inc |
2 Q |
63.72% |
5.36% |
80.61% |
-1.53% |
| Anixa Biosciences Inc |
2 Q |
- |
- |
- |
-40.67% |
| Annexon Inc |
2 Q |
- |
- |
- |
-64.31% |
| An2 Therapeutics Inc |
2 Q |
- |
- |
- |
-58.52% |
| Annovis Bio inc |
2 Q |
- |
- |
- |
-120.97% |
| Apexigen Inc |
2 Q |
- |
- |
- |
-910.95% |
| Apellis Pharmaceuticals Inc |
2 Q |
- |
-128.5% |
-156.91% |
-212.85% |
| Applied Therapeutics Inc |
2 Q |
- |
- |
- |
-5544.59% |
| Aptorum Group Limited |
4 Q |
- |
- |
- |
-154.88% |
| Aprea Therapeutics Inc |
2 Q |
- |
- |
- |
-55.23% |
| Aptinyx Inc |
1 Q |
- |
- |
- |
-157.89% |
| Aptevo Therapeutics Inc |
2 Q |
- |
- |
- |
-95.36% |
| Aquestive Therapeutics Inc |
2 Q |
50.03% |
-43.74% |
-33.58% |
- |
| Aravive Inc |
2 Q |
- |
- |
0% |
- |
| Arcturus Therapeutics Holdings Inc |
2 Q |
- |
-499.57% |
- |
31.17% |
| Aridis Pharmaceuticals Inc |
1 Q |
- |
-629.94% |
-345.56% |
- |
| Ardelyx inc |
1 Q |
86.48% |
-235.49% |
-32.13% |
-76.72% |
| Arena Pharmaceuticals Inc |
4 Q |
- |
-288164.81% |
-300150% |
-69.83% |
| Arcutis Biotherapeutics Inc |
2 Q |
85.05% |
-1367.84% |
- |
-188.88% |
| Artelo Biosciences Inc |
2 Q |
- |
- |
- |
-50.18% |
| Arvinas Inc |
2 Q |
- |
-122.2% |
-72.66% |
-78.32% |
| Arrowhead Pharmaceuticals Inc |
2 Q |
- |
-657.98% |
-186.7% |
-44.34% |
| Aslan Pharmaceuticals Limited |
4 Q |
- |
- |
- |
-377.64% |
| Assembly Biosciences Inc |
2 Q |
- |
- |
- |
-104.9% |
| Ascendis Pharma A |
4 Q |
76.28% |
-1139.63% |
- |
-221.45% |
| Assertio Holdings inc |
2 Q |
88.36% |
20.66% |
3.83% |
45.16% |
| Atai Life Sciences N v |
2 Q |
- |
-19634.3% |
-26043.6% |
-59.12% |
| Alterity Therapeutics Limited |
2 Q |
- |
- |
- |
0% |
| Athersys Inc |
2 Q |
- |
-26375.51% |
- |
- |
| 180 Life Sciences Corp |
2 Q |
- |
- |
- |
-403.09% |
| Actinium Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-74.73% |
| Athenex Inc |
4 Q |
75.22% |
-425.38% |
-143.85% |
- |
| Atossa Therapeutics Inc |
2 Q |
- |
- |
- |
-27.49% |
| Adhera Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Avenue Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Astria Therapeutics inc |
2 Q |
- |
- |
- |
-26.29% |
| Aurinia Pharmaceuticals Inc |
2 Q |
96.23% |
-27.7% |
-17.58% |
-18.05% |
| Avadel Pharmaceuticals Plc |
2 Q |
97.59% |
-4306.95% |
-2233.02% |
-799.61% |
| Aveo Pharmaceuticals Inc |
3 Q |
86.98% |
-10.73% |
23.74% |
-81.66% |
| Atea Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-16.82% |
| Aerovate Therapeutics inc |
1 Q |
- |
- |
- |
-48.7% |
| Avalo Therapeutics Inc |
2 Q |
-10.11% |
-1274.18% |
-1621.77% |
- |
| Axim Biotechnologies Inc |
2 Q |
- |
-37499.19% |
- |
- |
| Axsome Therapeutics Inc |
2 Q |
90.15% |
-143.83% |
- |
-112.21% |
| Aytu Biopharma inc |
1 Q |
56.06% |
-31.67% |
-1.42% |
-71.3% |
| Astrazeneca Plc |
4 Q |
72.06% |
7.42% |
13.9% |
8.89% |
| Azitra Inc |
2 Q |
- |
-2575.31% |
- |
- |
| Bridgebio Pharma Inc |
2 Q |
63.5% |
-9792.99% |
-6731.57% |
- |
| Atreca inc |
2 Q |
- |
- |
- |
-120.73% |
| Briacell Therapeutics Corp |
1 Q |
- |
- |
- |
0% |
| Bicycle Therapeutics Plc |
2 Q |
- |
-373.81% |
- |
-54.71% |
| Bioadaptives Inc |
2 Q |
63.7% |
-6152.93% |
- |
- |
| Biodexa Pharmaceuticals Plc |
4 Q |
- |
-1095.28% |
0% |
-242.13% |
| Biodelivery Sciences International Inc |
4 Q |
84% |
- |
31.51% |
63.64% |
| Betterlife Pharma Inc. |
4 Q |
- |
- |
- |
-14.06% |
| Bullfrog Ai Holdings Inc |
2 Q |
- |
- |
- |
- |
| Biofrontera Inc |
2 Q |
- |
-168.21% |
-154.79% |
-128.79% |
| Beigene Ltd |
2 Q |
83.87% |
-64.03% |
-20.53% |
-40.66% |
| Bausch Health Companies Inc |
2 Q |
70.47% |
1.25% |
2.63% |
-68.17% |
| Biohaven Ltd |
2 Q |
- |
- |
- |
-195.16% |
| Biora Therapeutics Inc |
2 Q |
- |
-890350% |
-200550% |
- |
| Biovie Inc |
3 Q |
- |
- |
- |
491.96% |
| Bioxytran Inc |
2 Q |
- |
- |
- |
- |
| Bellicum Pharmaceuticals Inc |
2 Q |
- |
-245066.67% |
- |
- |
| Bellerophon Therapeutics inc |
2 Q |
- |
- |
- |
-189.42% |
| Biolinerx Ltd |
4 Q |
- |
- |
- |
-53.21% |
| Biomea Fusion Inc |
2 Q |
- |
- |
- |
-74.75% |
| Biomarin Pharmaceutical Inc |
2 Q |
78.48% |
9.41% |
19.2% |
2.15% |
| Bristol myers Squibb Company |
2 Q |
74.38% |
18.5% |
-5.55% |
24.97% |
| Benitec Biopharma Inc |
2 Q |
- |
-66585.71% |
-22657.14% |
-274.34% |
| Bolt Biotherapeutics Inc |
2 Q |
- |
-1260.08% |
-96.65% |
-46.56% |
| Blueprint Medicines Corporation |
2 Q |
95.96% |
-230.66% |
-161.74% |
-117.88% |
| Bio path Holdings Inc |
2 Q |
- |
- |
- |
-152.81% |
| Biophytis Sa |
4 Q |
- |
- |
- |
-547.71% |
| Bespoke Extracts Inc |
2 Q |
37.74% |
-246.97% |
-1.28% |
- |
| Bioxcel Therapeutics Inc |
2 Q |
94.31% |
-11710.07% |
-8309.85% |
-309.07% |
| Blue Water Biotech Inc |
1 Q |
- |
- |
- |
-64.24% |
| Beyondspring Inc |
4 Q |
- |
-2685.42% |
-5026.79% |
- |
| Calithera Biosciences Inc |
4 Q |
- |
- |
- |
-107.94% |
| Calcimedica Inc |
2 Q |
- |
- |
- |
-147.85% |
| Calliditas Therapeutics Ab |
4 Q |
98.11% |
-51.35% |
- |
-4.4% |
| Can fite Biopharma Ltd |
4 Q |
- |
-1255.93% |
-478.77% |
-224.17% |
| Capricor Therapeutics inc |
2 Q |
- |
-188.04% |
-19.61% |
-323.4% |
| Cara Therapeutics inc |
2 Q |
79.55% |
-454.05% |
- |
-75.82% |
| Carisma Therapeutics Inc |
2 Q |
- |
-2.47% |
- |
-19.43% |
| Casi Pharmaceuticals inc |
4 Q |
63.28% |
-93.39% |
46.03% |
-90.31% |
| Cymabay Therapeutics Inc |
2 Q |
- |
-2.61% |
-76.31% |
-104.52% |
| Catalyst Biosciences Inc |
2 Q |
- |
- |
- |
- |
| Chemocentryx Inc. |
2 Q |
96.59% |
-134.54% |
16.23% |
-48.52% |
| Avid Bioservices Inc |
2 Q |
11.05% |
-5.64% |
-36.78% |
-1.66% |
| Cardax Inc |
1 Q |
63.3% |
-1321.67% |
37.74% |
- |
| Celularity Inc |
2 Q |
92.95% |
-1632.03% |
-185.43% |
-51.93% |
| Chembio Diagnostics Inc |
4 Q |
45.78% |
-8.27% |
-27.8% |
-113.57% |
| Cen Biotech Inc |
3 Q |
- |
-264.15% |
-94.3% |
- |
| Cerevel Therapeutics Holdings Inc |
2 Q |
- |
- |
- |
-83.19% |
| Contrafect Corporation |
2 Q |
- |
- |
- |
- |
| China Health Industries Holdings Inc |
1 Q |
10.89% |
-1355.47% |
- |
-0.36% |
| Chiasma Inc |
1 Q |
96.52% |
-1587.73% |
- |
-113.57% |
| Cincor Pharma Inc |
3 Q |
- |
- |
- |
0% |
| Cingulate Inc |
2 Q |
- |
- |
- |
-1235.85% |
| Checkpoint Therapeutics inc |
2 Q |
- |
-53293.55% |
0% |
- |
| Cell Source Inc |
1 Q |
- |
- |
- |
- |
| Clene Inc |
2 Q |
75.46% |
-9346.84% |
-40.89% |
-1416.17% |
| Cellectar Biosciences Inc |
2 Q |
- |
- |
- |
-419.32% |
| Clearside Biomedical Inc |
2 Q |
79.08% |
-894.5% |
-630.06% |
-533.87% |
| Clever Leaves Holdings Inc |
2 Q |
57.68% |
-76.07% |
-32.75% |
-125.46% |
| Clovis Oncology inc |
3 Q |
76.31% |
-182.68% |
-118.25% |
- |
| Chemomab Therapeutics Ltd |
1 Q |
- |
- |
- |
77.93% |
| Clearmind Medicine Inc |
3 Q |
- |
- |
- |
- |
| Compass Pathways Plc |
2 Q |
- |
- |
- |
-57.87% |
| Comera Life Sciences Holdings Inc |
2 Q |
82.21% |
-448.06% |
-337.2% |
- |
| Chimerix inc |
2 Q |
- |
-71446.15% |
- |
72.53% |
| Cnbx Pharmaceuticals Inc |
2 Q |
- |
-49.87% |
-1.16% |
- |
| Concert Pharmaceuticals Inc |
3 Q |
- |
-361300% |
-550700% |
-165.03% |
| Cns Pharmaceuticals Inc |
2 Q |
- |
-51541.07% |
-10654.7% |
-318.2% |
| Constellation Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-33.12% |
| Centessa Pharmaceuticals Plc |
2 Q |
- |
- |
- |
-54% |
| Connect Biopharma Holdings Limited |
4 Q |
- |
- |
- |
-72.67% |
| Context Therapeutics Inc |
2 Q |
- |
- |
- |
-59.67% |
| Cocrystal Pharma Inc |
2 Q |
- |
- |
- |
-51.18% |
| Cogent Biosciences Inc |
2 Q |
- |
- |
- |
-56.31% |
| Collegium Pharmaceutical inc |
2 Q |
54.76% |
9.65% |
9.47% |
-5.78% |
| Corcept Therapeutics Inc |
2 Q |
98.66% |
23.24% |
-108.37% |
19.57% |
| Coya Therapeutics Inc |
2 Q |
- |
- |
- |
0% |
| China Pharma Holdings Inc |
2 Q |
-13.36% |
-54.02% |
-24.14% |
-77.39% |
| Cumberland Pharmaceuticals Inc |
2 Q |
86.03% |
7.92% |
17.11% |
-5.02% |
| Cannapharmarx Inc |
1 Q |
- |
- |
- |
- |
| Catalyst Pharmaceuticals Inc |
2 Q |
87.9% |
37.92% |
30.67% |
36.13% |
| Corbus Pharmaceuticals Holdings Inc |
2 Q |
- |
- |
- |
-183.08% |
| Cormedix Inc |
2 Q |
- |
- |
- |
-68.87% |
| Crinetics Pharmaceuticals Inc |
2 Q |
- |
-5159.82% |
-166.09% |
-61.19% |
| Corvus Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-71.23% |
| Cti Biopharma Corp |
1 Q |
94.92% |
-55.66% |
-25.75% |
- |
| Innovation Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-112.57% |
| Catalent Inc |
2 Q |
34.56% |
1.19% |
-23.23% |
8.71% |
| Cytomx Therapeutics Inc |
2 Q |
- |
-4.4% |
4.77% |
- |
| Citius Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-31.01% |
| Cue Biopharma Inc |
2 Q |
- |
-954.05% |
-236.61% |
-95.35% |
| Avenir Wellness Solutions Inc |
4 Q |
21.22% |
-806.55% |
-169.3% |
-1323.6% |
| Cadrenal Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Cv Sciences Inc |
2 Q |
46.21% |
-34.64% |
26.25% |
45.08% |
| Cohbar Inc |
2 Q |
- |
- |
- |
-88.89% |
| Celyad Oncology Sa |
4 Q |
- |
- |
- |
-614.13% |
| Cyclacel Pharmaceuticals Inc |
2 Q |
- |
-1447.18% |
-340.75% |
-179.85% |
| Cyclerion Therapeutics Inc |
1 Q |
- |
- |
- |
-270.55% |
| Cytodyn Inc |
2 Q |
- |
- |
- |
- |
| Cryoport inc |
2 Q |
43.38% |
-35.7% |
50.47% |
-8.42% |
| Cyteir Therapeutics Inc |
2 Q |
- |
- |
- |
-28.93% |
| Cytokinetics Incorporated |
2 Q |
- |
-14837.02% |
-3944.87% |
- |
| Altamira Therapeutics Ltd |
4 Q |
-372.44% |
-8680.31% |
0% |
- |
| Dar Bioscience Inc |
2 Q |
- |
- |
- |
-400.6% |
| Day One Biopharmaceuticals Inc |
2 Q |
- |
- |
- |
-7.81% |
| Decibel Therapeutics Inc |
2 Q |
- |
- |
- |
-84.03% |
| Deciphera Pharmaceuticals Inc |
2 Q |
99.55% |
-126.78% |
-87.27% |
-47.99% |
| Journey Medical Corporation |
2 Q |
54.77% |
-48.7% |
-53.1% |
-309.66% |
| Diffusion Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-69.97% |
| Dice Therapeutics Inc |
2 Q |
- |
- |
- |
-22.01% |
| Diamedica Therapeutics Inc |
2 Q |
- |
- |
- |
-43.1% |
| Dominari Holdings Inc |
2 Q |
- |
-12201.41% |
-8359.15% |
-36.19% |
| Dermata Therapeutics Inc |
2 Q |
- |
- |
- |
-108.55% |
| Dicerna Pharmaceuticals Inc |
3 Q |
- |
-27.12% |
-88.09% |
-103.08% |
| Durect Corp |
2 Q |
82.75% |
-537.29% |
-362.13% |
-179.02% |
| Bright Minds Biosciences Inc |
3 Q |
- |
- |
- |
-141.95% |
| Design Therapeutics Inc |
2 Q |
- |
- |
- |
-23.25% |
| Dynavax Technologies Corporation |
2 Q |
77.53% |
5.69% |
87.09% |
19.86% |
| Dyne Therapeutics Inc |
2 Q |
- |
- |
- |
-79.63% |
| Emergent Biosolutions Inc |
2 Q |
43.59% |
-77.33% |
-101.86% |
-48.73% |
| Edesa Biotech Inc |
2 Q |
- |
- |
- |
-103.72% |
| Effector Therapeutics Inc |
2 Q |
- |
- |
- |
-1125.65% |
| Eagle Pharmaceuticals inc |
2 Q |
73.92% |
7.99% |
-10.12% |
4.98% |
| Elanco Animal Health Inc |
2 Q |
58.94% |
-9.18% |
4.64% |
-1.35% |
| Eledon Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-89.2% |
| Elite Pharmaceuticals Inc |
2 Q |
54.29% |
13.05% |
14.26% |
11.12% |
| Enliven Therapeutics Inc |
2 Q |
- |
- |
- |
-2.16% |
| Eliem Therapeutics Inc |
2 Q |
- |
- |
- |
-36.52% |
| Emmaus Life Sciences Inc |
2 Q |
95.28% |
-13.77% |
-3.84% |
- |
| Endo International Plc |
2 Q |
57.24% |
4.29% |
-6.41% |
- |
| Enlivex Therapeutics Ltd |
4 Q |
- |
- |
- |
-54.64% |
| Enochian Biosciences Inc |
1 Q |
- |
- |
- |
-154.69% |
| Ensysce Biosciences Inc |
2 Q |
- |
-456.56% |
- |
- |
| Enanta Pharmaceuticals Inc |
2 Q |
- |
-206.78% |
- |
-46.77% |
| Enveric Biosciences Inc |
2 Q |
- |
- |
- |
-168.47% |
| Evolus Inc |
2 Q |
70.19% |
-36.76% |
20.76% |
-556.51% |
| Essa Pharma inc |
2 Q |
- |
- |
- |
-17.26% |
| Epizyme Inc. |
2 Q |
81.22% |
-129.85% |
-23.09% |
- |
| Equillium Inc |
2 Q |
- |
-36.64% |
12.29% |
-62.45% |
| Eqrx Inc |
2 Q |
- |
- |
- |
-19.59% |
| Erasca Inc |
2 Q |
- |
- |
- |
-59.26% |
| Eterna Therapeutics Inc |
2 Q |
- |
- |
- |
-270.22% |
| Esperion Therapeutics Inc |
2 Q |
- |
-193.65% |
-24.98% |
- |
| 89bio Inc |
2 Q |
- |
- |
- |
-39.8% |
| Eton Pharmaceuticals Inc |
2 Q |
82.88% |
39.03% |
58.71% |
-1.79% |
| Earth Science Tech Inc |
2 Q |
67.64% |
-40.79% |
25.57% |
- |
| Entasis Therapeutics Holdings Inc |
1 Q |
- |
- |
- |
-145.48% |
| Evofem Biosciences Inc |
2 Q |
6.71% |
-348.17% |
-36.53% |
- |
| Evelo Biosciences Inc |
2 Q |
- |
- |
- |
- |
| Evotec Se |
4 Q |
23.16% |
-23.38% |
56.24% |
-14.8% |
| Evoke Pharma Inc |
2 Q |
- |
-165.1% |
-106.63% |
-258.2% |
| Edgewise Therapeutics inc |
2 Q |
- |
- |
- |
-3.16% |
| Eyenovia inc |
2 Q |
- |
- |
- |
-158.92% |
| Fortress Biotech Inc |
2 Q |
55.33% |
-341.08% |
-377.95% |
-579.62% |
| Forte Biosciences Inc |
2 Q |
- |
- |
- |
-68.61% |
| Fibrogen Inc |
2 Q |
87.12% |
-197.84% |
-81.15% |
- |
| Foghorn Therapeutics Inc |
2 Q |
- |
-526.65% |
28.09% |
- |
| Homology Medicines Inc |
2 Q |
- |
-9899.44% |
- |
-80.15% |
| Flora Growth Corp |
4 Q |
- |
- |
- |
0% |
| Flexion Therapeutics Inc |
3 Q |
82.52% |
-142.14% |
- |
- |
| Amicus Therapeutics inc |
2 Q |
90.46% |
-45.8% |
52.28% |
-157.79% |
| Frequency Therapeutics Inc |
2 Q |
- |
- |
- |
-107.67% |
| F star Therapeutics Inc |
3 Q |
- |
-1636.18% |
-1470.4% |
-56.71% |
| Fulcrum Therapeutics Inc |
2 Q |
- |
-2702.61% |
-87.27% |
-39.69% |
| First Wave Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Galectin Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Gain Therapeutics inc |
2 Q |
- |
- |
- |
-130.19% |
| Generation Bio Co |
2 Q |
- |
-3530.23% |
- |
-45.12% |
| Global Blood Therapeutics Inc. |
2 Q |
98.03% |
-115.26% |
-182.63% |
-170.37% |
| The Greater Cannabis Company Inc |
2 Q |
- |
- |
- |
- |
| Geron Corp |
2 Q |
- |
-169748.28% |
-192082.76% |
-84.19% |
| Gh Research Plc |
4 Q |
- |
- |
- |
-3.32% |
| Guardion Health Sciences Inc |
2 Q |
55.54% |
-52.12% |
-18.17% |
-89.69% |
| Galmed Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
133.1% |
| Galapagos Nv |
4 Q |
97.61% |
-43.14% |
0% |
-4.09% |
| Gelesis Holdings Inc |
2 Q |
55.01% |
-693.86% |
- |
- |
| Greenwich Lifesciences Inc |
2 Q |
- |
- |
- |
-49.85% |
| Galecto Inc |
2 Q |
- |
- |
- |
-90.21% |
| Glycomimetics Inc |
1 Q |
- |
- |
- |
-55.48% |
| Generex Biotechnology Corp |
1 Q |
-218.89% |
- |
- |
- |
| Genelux Corporation |
2 Q |
- |
- |
- |
- |
| Genprex Inc |
2 Q |
- |
- |
- |
-149.6% |
| Gossamer Bio Inc |
2 Q |
- |
- |
- |
- |
| Geovax Labs Inc |
2 Q |
- |
- |
- |
-78.52% |
| Structure Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Gracell Biotechnologies Inc |
4 Q |
- |
- |
- |
-44.16% |
| Grifols Sa |
4 Q |
- |
- |
- |
3.21% |
| Gri Bio Inc |
2 Q |
- |
- |
- |
-476.51% |
| Galera Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Glaxosmithkline Plc |
4 Q |
65.99% |
14.94% |
12.53% |
23.88% |
| Globestar Therapeutics Corporation |
2 Q |
- |
- |
- |
- |
| Gt Biopharma Inc |
2 Q |
- |
- |
- |
-111.87% |
| G1 Therapeutics Inc |
2 Q |
- |
20.55% |
-29.07% |
-143.26% |
| Gw Pharmaceuticals Plc |
1 Q |
92.26% |
-12.91% |
-18.79% |
-2.83% |
| Hutchmed china Limited |
4 Q |
36.99% |
-84.52% |
-27.92% |
-56.59% |
| Hcw Biologics Inc |
2 Q |
19.33% |
-691.13% |
-1756.67% |
-53% |
| Hepion Pharmaceuticals inc |
2 Q |
- |
- |
- |
-98.93% |
| Humanigen Inc |
1 Q |
- |
-1892.31% |
-3194.12% |
- |
| Hillstream Biopharma Inc |
2 Q |
- |
- |
- |
-188.47% |
| Hookipa Pharma inc |
2 Q |
- |
-672.49% |
- |
-66.35% |
| Hoth Therapeutics Inc |
2 Q |
- |
-120996.83% |
-93649.61% |
-114.51% |
| Werewolf Therapeutics Inc |
2 Q |
- |
-63.09% |
-128.83% |
-33.23% |
| Inhibitor Therapeutics Inc |
2 Q |
- |
- |
- |
229.02% |
| Harmony Biosciences Holdings inc |
2 Q |
81.37% |
25.56% |
21.57% |
47.82% |
| Harrow Health Inc |
2 Q |
70.12% |
-12.64% |
10.48% |
-90.85% |
| Heron Therapeutics Inc |
2 Q |
36.53% |
-132.42% |
-42.91% |
- |
| Hst Global Inc |
2 Q |
- |
- |
- |
- |
| Histogen Inc |
2 Q |
- |
-41780% |
-47980% |
-100.61% |
| Fsd Pharma Inc |
4 Q |
- |
- |
- |
-77.29% |
| Horizon Therapeutics Public Limited Company |
2 Q |
76.8% |
13.46% |
16.21% |
8.54% |
| Ibio inc |
2 Q |
- |
- |
- |
-260.14% |
| Intercept Pharmaceuticals inc |
2 Q |
99.78% |
-7% |
88.79% |
248.75% |
| Ideaya Biosciences Inc |
2 Q |
- |
-787.98% |
- |
-19.09% |
| Inflarx N v |
4 Q |
- |
- |
- |
-33.37% |
| Igc Pharma Inc |
2 Q |
45.95% |
-373.87% |
-265.41% |
-64.87% |
| Igm Biosciences Inc |
2 Q |
- |
- |
- |
-84.19% |
| Intelgenx Technologies Corp |
1 Q |
-191.36% |
-1804.94% |
- |
- |
| I mab |
4 Q |
- |
- |
- |
-86.16% |
| Immunogen inc |
2 Q |
- |
-5.11% |
- |
-76.92% |
| Imago Biosciences Inc |
3 Q |
- |
- |
- |
-13.66% |
| Immutep Ltd |
2 Q |
- |
-753.57% |
- |
-40.81% |
| Immix Biopharma Inc |
4 Q |
- |
- |
- |
-48.64% |
| Immunome Inc |
1 Q |
- |
-180.63% |
- |
-135.42% |
| Imunon Inc |
2 Q |
- |
- |
- |
-102.76% |
| Impel Pharmaceuticals Inc |
2 Q |
52.86% |
-115.6% |
-319.03% |
- |
| Immuron Limited |
2 Q |
88.43% |
-255.78% |
- |
-19.3% |
| Immuneering Corporation |
2 Q |
- |
- |
- |
-46.67% |
| Immune Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Immunic Inc |
2 Q |
- |
- |
- |
-132.61% |
| Integrated Biopharma Inc |
2 Q |
7.96% |
0.32% |
-9.8% |
-0.18% |
| Intercure Ltd |
4 Q |
39.9% |
11.26% |
9.75% |
8.39% |
| Indaptus Therapeutics Inc |
2 Q |
- |
- |
- |
-63.55% |
| Infinity Pharmaceuticals Inc |
2 Q |
- |
-1707.72% |
- |
- |
| Inmed Pharmaceuticals Inc |
2 Q |
31.15% |
78.14% |
-19.42% |
-103.14% |
| Insmed Inc |
2 Q |
78.84% |
-312.2% |
-454.04% |
- |
| Innoviva Inc |
1 Q |
97.96% |
44.39% |
-187.18% |
37.23% |
| Inozyme Pharma Inc |
2 Q |
- |
- |
- |
-58.78% |
| Io Biotech Inc |
2 Q |
- |
- |
- |
-56.79% |
| Ionis Pharmaceuticals Inc |
1 Q |
98.97% |
-95.25% |
24.94% |
-52.07% |
| Immunoprecise Antibodies Ltd |
1 Q |
55.95% |
-128.53% |
0% |
-45.95% |
| Intellipharmaceutics International Inc |
4 Q |
- |
-4400.55% |
- |
- |
| Disc Medicine Inc |
2 Q |
- |
- |
- |
-28.57% |
| Ironwood Pharmaceuticals inc |
1 Q |
- |
39.78% |
-27.44% |
122.32% |
| International Stem Cell Corporation |
2 Q |
61.27% |
14.07% |
23.85% |
- |
| Iveric Bio Inc |
1 Q |
- |
- |
- |
-57% |
| Intra cellular Therapies Inc |
2 Q |
- |
-38.62% |
60.05% |
-28.63% |
| Iterum Therapeutics Plc |
2 Q |
- |
- |
- |
-260.09% |
| Inventiva S a |
4 Q |
- |
-445.64% |
- |
-109.15% |
| Jaguar Health inc |
2 Q |
81.65% |
-459.3% |
-214.5% |
-1157.69% |
| Janux Therapeutics Inc |
2 Q |
- |
-1656.39% |
- |
-21.45% |
| Jazz Pharmaceuticals Plc |
2 Q |
- |
10.91% |
11.95% |
-5.9% |
| Johnson and Johnson |
3 Q |
67.19% |
18.74% |
1.56% |
25.57% |
| Kineta Inc |
2 Q |
- |
7.27% |
-28.44% |
-1657.39% |
| Kala Bio inc |
2 Q |
- |
- |
- |
-58.6% |
| Kalvista Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-60.57% |
| Kyto Technology And Life Science Inc |
4 Q |
- |
- |
- |
13.86% |
| Kadmon holdings inc |
3 Q |
95.63% |
-232.46% |
47.23% |
-216.92% |
| Chinook Therapeutics Inc |
2 Q |
- |
-6641.27% |
- |
-58.28% |
| Kindred Biosciences Inc |
2 Q |
81.93% |
-258.07% |
- |
-54.55% |
| Kamada Ltd |
4 Q |
29.26% |
-2.15% |
0% |
-1.26% |
| Kiniksa Pharmaceuticals Ltd |
2 Q |
89.23% |
20.95% |
44.7% |
58.48% |
| Kinnate Biopharma Inc |
2 Q |
- |
- |
- |
-57.01% |
| Kiora Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-105.85% |
| Karyopharm Therapeutics Inc |
2 Q |
96.82% |
-86.83% |
-9.83% |
- |
| Kronos Bio Inc |
2 Q |
- |
-1595.55% |
- |
-51.01% |
| Keros Therapeutics Inc |
2 Q |
- |
- |
- |
-42.19% |
| Karuna Therapeutics Inc |
2 Q |
- |
- |
- |
-27.13% |
| Kintara Therapeutics Inc |
2 Q |
- |
- |
- |
-282.78% |
| Pasithea Therapeutics Corp |
2 Q |
- |
- |
- |
-41.47% |
| Kura Oncology Inc |
2 Q |
- |
- |
- |
-33.01% |
| Khosla Ventures Acquisition Co |
2 Q |
- |
- |
- |
- |
| Kazia Therapeutics Limited |
2 Q |
- |
-55.46% |
57.71% |
-22.25% |
| Kezar Life Sciences Inc |
2 Q |
- |
- |
- |
-31.81% |
| Landos Biopharma Inc |
2 Q |
- |
- |
- |
3.75% |
| Longboard Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-74.91% |
| 4d Pharma Plc |
4 Q |
- |
-4448.19% |
- |
-98.53% |
| Lannett Company Inc |
1 Q |
19.1% |
-127.69% |
-11.72% |
- |
| Legend Biotech Corporation |
4 Q |
- |
-430.12% |
- |
-81.96% |
| Lexaria Bioscience Corp |
2 Q |
86.32% |
-2558.85% |
-116.15% |
-194.81% |
| Lifevantage Corp |
2 Q |
80.16% |
3.65% |
3.86% |
7.7% |
| Ligand Pharmaceuticals Incorporated |
2 Q |
67.61% |
8.69% |
-228.64% |
3.99% |
| Longeveron Inc |
1 Q |
81.08% |
-948.65% |
-952.97% |
-11.82% |
| Lianbio |
2 Q |
- |
- |
- |
-0.1% |
| Lftd Partners Inc |
2 Q |
45.01% |
13.25% |
-11.35% |
7.12% |
| Lipella Pharmaceuticals Inc |
2 Q |
- |
-1442.39% |
-848.47% |
- |
| Lixte Biotechnology Holdings Inc |
2 Q |
- |
- |
- |
-133.96% |
| Eli Lilly And Company |
2 Q |
78.26% |
21.21% |
-10.24% |
59.9% |
| Liminal Biosciences Inc |
4 Q |
- |
- |
- |
36.05% |
| Landec Corporation |
1 Q |
26.27% |
-24.29% |
1.44% |
-36.52% |
| Lipocine Inc |
2 Q |
- |
-12925.26% |
- |
-36.05% |
| Leap Therapeutics inc |
2 Q |
- |
- |
- |
-136.66% |
| Liquidia Corporation |
2 Q |
85.98% |
-491.37% |
-129.88% |
-62.1% |
| Larimar Therapeutics Inc |
2 Q |
- |
- |
- |
-29.96% |
| Lucy Scientific Discovery Inc |
1 Q |
- |
- |
- |
- |
| Lantern Pharma Inc |
2 Q |
- |
- |
- |
-26.42% |
| Lumos Pharma Inc |
2 Q |
- |
-1694.69% |
-1171.92% |
-56.88% |
| Lexicon Pharmaceuticals Inc |
2 Q |
97.48% |
-14165.3% |
- |
-97.63% |
| Lyell Immunopharma Inc |
2 Q |
- |
-236629.63% |
- |
-26.4% |
| Merrimack Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-17.14% |
| Maia Biotechnology Inc |
2 Q |
- |
- |
- |
-65.5% |
| Marizyme Inc |
1 Q |
69.55% |
-1980.7% |
-140.38% |
-120.38% |
| Mustang Bio inc |
1 Q |
- |
- |
- |
-87.26% |
| Moleculin Biotech Inc |
2 Q |
- |
- |
- |
-59.57% |
| Seres Therapeutics Inc |
2 Q |
- |
36.81% |
- |
-1155.47% |
| Madrigal Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-285.72% |
| Medicenna Therapeutics Corp. |
1 Q |
- |
- |
- |
- |
| 23andme Holding Co |
2 Q |
50.56% |
-172.42% |
-119.48% |
-44.16% |
| Mei Pharma Inc |
2 Q |
- |
-688.33% |
- |
-88.04% |
| Macrogenics Inc |
2 Q |
98.04% |
- |
-879.31% |
5.46% |
| Magenta Therapeutics Inc |
2 Q |
- |
- |
- |
-71.92% |
| Mirum Pharmaceuticals Inc |
2 Q |
- |
-197.45% |
- |
-132.79% |
| Milestone Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-98.76% |
| Stealth Biotherapeutics Corp |
4 Q |
- |
- |
- |
- |
| Moonlake Immunotherapeutics |
2 Q |
- |
- |
- |
-38.87% |
| Mineralys Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Mallinckrodt Plc |
1 Q |
35.81% |
-24.37% |
4.18% |
-48.65% |
| Mannkind Corporation |
2 Q |
81.46% |
-10.83% |
0.65% |
- |
| Medicinova Inc |
2 Q |
- |
- |
- |
-18.02% |
| Monopar Therapeutics Inc |
2 Q |
- |
- |
- |
-100.87% |
| Morphosys Ag |
4 Q |
82.08% |
-286.43% |
61.13% |
-210.09% |
| Morphic Holding inc |
2 Q |
- |
- |
- |
-27.71% |
| Medicure Inc |
4 Q |
69.69% |
5.92% |
11.78% |
6.5% |
| Mereo Biopharma Group Plc |
4 Q |
- |
- |
- |
20.57% |
| Merck and Co Inc |
1 Q |
66.17% |
27.12% |
2.81% |
38.23% |
| Marker Therapeutics inc |
2 Q |
- |
- |
- |
-68.58% |
| Marinus Pharmaceuticals Inc |
2 Q |
93.65% |
-525.14% |
-314.37% |
-32.53% |
| Mersana Therapeutics inc |
2 Q |
- |
-509.73% |
55.44% |
-255.91% |
| Mirati Therapeutics Inc |
2 Q |
- |
-1292.28% |
-818.55% |
-79.37% |
| Merus N v |
2 Q |
- |
-305.78% |
-14.13% |
-69.89% |
| Maravai Lifesciences Holdings Inc |
2 Q |
37.21% |
-17.33% |
-75.4% |
19.61% |
| Musclepharm Corporation |
1 Q |
11.52% |
-48.1% |
-5.26% |
- |
| Metacrine Inc |
3 Q |
- |
- |
- |
-83.77% |
| Molecular Templates inc |
2 Q |
- |
- |
-1302.34% |
- |
| Matinas Biopharma Holdings Inc |
2 Q |
- |
- |
- |
-58.38% |
| Murphy Canyon Acquisition Corp |
2 Q |
- |
- |
- |
- |
| Mainz Biomed N v |
4 Q |
34.38% |
-4979.9% |
0% |
-187.2% |
| Myovant Sciences Ltd |
4 Q |
92.6% |
-57.5% |
-95.85% |
- |
| Innovation1 Biotech Inc |
2 Q |
- |
- |
- |
-2398.21% |
| Nature s Sunshine Products inc |
2 Q |
73.19% |
2.32% |
2.81% |
4.25% |
| Nascent Biotech Inc |
2 Q |
- |
-2572495.24% |
-774790.48% |
- |
| Nabriva Therapeutics Plc |
1 Q |
41.53% |
-114.62% |
-139.87% |
-365.53% |
| Neubase Therapeutics inc |
1 Q |
- |
- |
- |
-119.35% |
| Nanobiotix S a |
4 Q |
- |
-1194.33% |
- |
- |
| Novabay Pharmaceuticals Inc |
1 Q |
60.25% |
-4.41% |
-86.88% |
-36.44% |
| Nucana Plc |
4 Q |
- |
- |
- |
-105.28% |
| Neptune Wellness Solutions Inc |
2 Q |
26.45% |
-60.22% |
-5.77% |
- |
| Minerva Neurosciences Inc |
2 Q |
- |
- |
- |
- |
| Neximmune Inc |
2 Q |
- |
- |
- |
-161.71% |
| Ngm Biopharmaceuticals Inc |
2 Q |
- |
-2688.76% |
-1003.37% |
-70.78% |
| Nighthawk Biosciences inc |
2 Q |
41.67% |
-2122.56% |
-302.55% |
-79.5% |
| Nektar Therapeutics |
2 Q |
65.88% |
-249.39% |
-127.94% |
-100.89% |
| Nkarta Inc |
2 Q |
- |
- |
- |
-34.82% |
| Nls Pharmaceutics Ltd |
4 Q |
- |
- |
- |
-502.79% |
| Neoleukin Therapeutics Inc |
1 Q |
- |
- |
- |
-36.77% |
| 9 Meters Biopharma Inc |
1 Q |
- |
- |
- |
-584.98% |
| Nanomix Corp |
4 Q |
- |
- |
- |
- |
| Nanoviricides inc |
1 Q |
- |
- |
- |
-32.87% |
| Novan Inc |
1 Q |
59.41% |
-445.96% |
-5.62% |
-616.76% |
| Neurobo Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-60.64% |
| Nurix Therapeutics Inc |
2 Q |
- |
-79.14% |
82.76% |
-53.36% |
| Nrx Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-740.89% |
| Rebus Holdings Inc |
2 Q |
- |
- |
- |
- |
| Intec Pharma Ltd |
1 Q |
- |
- |
- |
-96.37% |
| Nuvation Bio Inc |
2 Q |
- |
- |
- |
-13.97% |
| Nuvalent Inc |
2 Q |
- |
- |
- |
-25.6% |
| Nuvectis Pharma inc |
1 Q |
- |
- |
- |
- |
| Novartis Ag |
4 Q |
70.12% |
13.42% |
23.94% |
11.7% |
| Northwest Biotherapeutics inc |
2 Q |
- |
-7446.27% |
-2371.64% |
- |
| Nexien Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Nextcure Inc |
2 Q |
- |
- |
- |
-43.74% |
| Theralink Technologies Inc |
2 Q |
75.26% |
- |
-90.31% |
- |
| Obseva Sa |
4 Q |
- |
-290.25% |
- |
-180.52% |
| Obseva Sa |
4 Q |
- |
-107.3% |
-255.45% |
0% |
| Ocean Biomedical Inc |
1 Q |
- |
- |
- |
- |
| Oculis Holding Ag |
4 Q |
- |
-4243.2% |
0% |
- |
| Ocular Therapeutix Inc |
2 Q |
91.41% |
-136.19% |
-81.79% |
-384.42% |
| Ocuphire Pharma Inc |
2 Q |
- |
-135.03% |
26.92% |
54.45% |
| Odonate Therapeutics Inc |
3 Q |
- |
- |
- |
-102.72% |
| Oragenics Inc |
2 Q |
- |
-23175.46% |
- |
-104.87% |
| Organon and Co |
2 Q |
60.2% |
15.05% |
-8.27% |
- |
| Olema Pharmaceuticals inc |
2 Q |
- |
- |
- |
-51.76% |
| Omeros Corporation |
2 Q |
- |
- |
- |
140.34% |
| Oncorus Inc |
1 Q |
- |
- |
- |
-134.31% |
| Oncosec Medical Incorporated |
4 Q |
- |
- |
- |
-868.37% |
| Oncternal Therapeutics Inc |
2 Q |
- |
-8458.49% |
- |
-75.67% |
| Oncolytics Biotech Inc |
4 Q |
- |
- |
- |
-93.71% |
| Onconova Therapeutics inc |
1 Q |
- |
-10312.5% |
-8101.79% |
-61.68% |
| Opko Health Inc |
2 Q |
57.42% |
-7.4% |
-1.03% |
-13.33% |
| Opiant Pharmaceuticals Inc |
3 Q |
- |
-5703.35% |
-2759.19% |
-97.18% |
| Optinose Inc |
2 Q |
86.78% |
13.23% |
-64.86% |
- |
| Organogenesis Holdings Inc |
2 Q |
77.57% |
4.53% |
0.08% |
3.42% |
| Orgenesis Inc |
2 Q |
53.66% |
52.49% |
-36.17% |
37.77% |
| Oric Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-40.74% |
| Oramed Pharmaceuticals Inc |
2 Q |
- |
- |
-2572.26% |
15.32% |
| Orphazyme A |
4 Q |
- |
-1731.11% |
- |
-100.97% |
| Otonomy Inc |
3 Q |
- |
- |
- |
-137.86% |
| Oncotelic Therapeutics Inc |
2 Q |
- |
- |
- |
-91.82% |
| Ovid Therapeutics Inc |
2 Q |
- |
-16544.44% |
- |
-38.92% |
| One World Products Inc |
2 Q |
-76% |
-759800% |
- |
- |
| Phibro Animal Health Corporation |
2 Q |
30.14% |
4.52% |
1.59% |
12.01% |
| Prestige Consumer Healthcare Inc |
2 Q |
55.5% |
43.77% |
-1.4% |
-5.55% |
| Panbela Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Puma Biotechnology Inc |
2 Q |
78.27% |
3.9% |
-2.54% |
-9.76% |
| Rapid Therapeutic Science Laboratories Inc |
2 Q |
- |
- |
- |
- |
| Pacira Biosciences inc |
2 Q |
71.55% |
15.2% |
30.25% |
-0.59% |
| Processa Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-233.27% |
| Procyon Corporation |
2 Q |
77.94% |
0.62% |
10.61% |
-1.91% |
| Pds Biotechnology Corp |
2 Q |
- |
- |
- |
-116.12% |
| Pepgen Inc |
2 Q |
- |
- |
- |
-40.53% |
| Pfizer Inc |
1 Q |
61.09% |
30.67% |
2.06% |
32.65% |
| Precigen Inc |
2 Q |
3.96% |
-1149.92% |
-395.81% |
14.31% |
| Pharming Group N v |
4 Q |
91.46% |
6.65% |
99.77% |
7.82% |
| Phasebio Pharmaceuticals Inc. |
2 Q |
- |
-8012.02% |
-5232.69% |
- |
| Phathom Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Phio Pharmaceuticals Corp |
2 Q |
- |
- |
- |
-119.85% |
| Pharvaris N v |
4 Q |
- |
- |
- |
-28.63% |
| Pieris Pharmaceuticals Inc |
2 Q |
- |
19.83% |
25.91% |
-90.41% |
| Peak Pharmaceuticals Inc |
4 Q |
- |
- |
- |
- |
| Protokinetix Incorporated |
2 Q |
- |
- |
- |
-499.85% |
| Pliant Therapeutics Inc |
2 Q |
- |
-16609.68% |
-19183.87% |
-33.1% |
| Plx Pharma Inc |
3 Q |
-278.24% |
-2201.3% |
-2563.73% |
-114.93% |
| Priveterra Acquisition Corp |
2 Q |
- |
- |
- |
- |
| Promis Neurosciences inc |
2 Q |
- |
- |
- |
- |
| Pmv Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-31.05% |
| Point Biopharma Global Inc |
2 Q |
- |
-522.23% |
-1106.61% |
22.69% |
| Purple Biotech Ltd |
4 Q |
- |
- |
- |
46.2% |
| Propanc Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Praxis Precision Medicines Inc |
2 Q |
- |
-4393.34% |
- |
-178.6% |
| Pardes Biosciences Inc |
2 Q |
- |
- |
- |
-43.36% |
| Painreform Ltd |
4 Q |
- |
- |
- |
-40.07% |
| Perrigo Company Plc |
1 Q |
31.46% |
-0.22% |
8.03% |
2.85% |
| Prelude Therapeutics Inc |
3 Q |
- |
- |
- |
10.79% |
| Procaps Group S a |
4 Q |
58.44% |
10.38% |
0% |
- |
| Prophase Labs Inc |
2 Q |
51.8% |
-27.63% |
-46.51% |
-6.97% |
| Proqr Therapeutics N v |
4 Q |
- |
- |
- |
0% |
| Prothena Corporation Public Limited Company |
2 Q |
- |
-1358.42% |
- |
-25.43% |
| Puretech Health Plc |
4 Q |
- |
-237.32% |
- |
-6.77% |
| Paratek Pharmaceuticals Inc |
1 Q |
80.01% |
-64.49% |
34.51% |
- |
| Provention Bio Inc |
4 Q |
- |
-307.75% |
-539.56% |
-103.36% |
| Ptc Therapeutics inc |
1 Q |
- |
-63.05% |
-28.28% |
- |
| Protagonist Therapeutics inc |
2 Q |
- |
- |
- |
-56.78% |
| Protagenic Therapeutics Inc new |
4 Q |
- |
- |
- |
-45.47% |
| Palatin Technologies Inc |
2 Q |
- |
-608.11% |
-660.79% |
-319.15% |
| Petros Pharmaceuticals inc |
1 Q |
78.13% |
-55.01% |
-43.93% |
- |
| Pulmatrix Inc |
4 Q |
- |
-246.84% |
-1066.28% |
-51.13% |
| Provectus Biopharmaceuticals Inc |
2 Q |
- |
-515.97% |
23.3% |
- |
| Paxmedica Inc |
3 Q |
- |
- |
- |
- |
| Pyxis Oncology Inc |
2 Q |
- |
- |
- |
-61.15% |
| Q Biomed inc |
1 Q |
- |
- |
- |
- |
| Qualigen Therapeutics Inc |
2 Q |
- |
-215.59% |
-182.95% |
-236.35% |
| Qilian International Holding Group Limited |
3 Q |
9.6% |
2.11% |
1.14% |
2.49% |
| Uniqure N v |
2 Q |
- |
-2827.17% |
- |
-44.91% |
| Rain Oncology Inc |
2 Q |
- |
- |
- |
-91.93% |
| Rani Therapeutics Holdings Inc |
2 Q |
- |
- |
- |
-102.15% |
| Rapt Therapeutics Inc |
2 Q |
- |
- |
- |
-46.21% |
| Ultragenyx Pharmaceutical Inc |
2 Q |
90.85% |
-147.57% |
14.9% |
-246.23% |
| Rasna Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Rocket Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-57.83% |
| Arcus Biosciences Inc |
2 Q |
- |
-258.62% |
-27.59% |
-45.58% |
| Redhill Biopharma Ltd |
4 Q |
46.06% |
- |
47.4% |
- |
| Radius Health inc. |
2 Q |
90.43% |
-21.85% |
1.5% |
- |
| Dr Reddy s Laboratories Limited |
1 Q |
56.65% |
18.32% |
0% |
19.5% |
| Regeneron Pharmaceuticals Inc |
2 Q |
93.91% |
30.66% |
-62.67% |
18.77% |
| Reata Pharmaceuticals Inc |
2 Q |
- |
- |
-158.7% |
- |
| Revelation Biosciences Inc |
2 Q |
- |
- |
- |
37.76% |
| Regen Biopharma Inc |
2 Q |
- |
-313.58% |
-274.99% |
- |
| Regulus Therapeutics Inc |
1 Q |
- |
- |
- |
-77.06% |
| Regenerx Biopharmaceuticals inc |
1 Q |
- |
-2007.3% |
-986.62% |
- |
| Rigel Pharmaceuticals Inc |
2 Q |
96% |
-24.55% |
31.72% |
- |
| Relmada Therapeutics Inc |
2 Q |
- |
- |
- |
-94.92% |
| Rallybio Corporation |
2 Q |
- |
- |
- |
-47.35% |
| Rockwell Medical inc |
4 Q |
-14.88% |
-59.68% |
-67.48% |
-225.3% |
| Avidity Biosciences Inc |
2 Q |
- |
-2030.44% |
- |
-37.33% |
| Transcode Therapeutics Inc |
2 Q |
- |
- |
- |
-557.17% |
| Renovorx Inc |
2 Q |
- |
- |
- |
-210.63% |
| Roivant Sciences Ltd |
2 Q |
- |
-1516.12% |
-1121.29% |
-74.08% |
| Reneo Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-56.76% |
| Royalty Pharma Plc |
2 Q |
55.18% |
65.28% |
36.68% |
4.76% |
| Repare Therapeutics Inc |
2 Q |
- |
-39.49% |
-19.56% |
-1.14% |
| Respirerx Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Rvl Pharmaceuticals Plc |
2 Q |
86.32% |
-326.71% |
-184.37% |
-155.18% |
| Revance Therapeutics Inc |
2 Q |
69.71% |
-115.8% |
7.84% |
-5.14% |
| Reviva Pharmaceuticals Holdings Inc |
2 Q |
- |
- |
- |
-306.16% |
| Prometheus Biosciences Inc |
1 Q |
- |
-3699.19% |
-19388.87% |
-33.5% |
| Rhythm Pharmaceuticals inc |
2 Q |
88.37% |
-242.98% |
31.34% |
-84.39% |
| Rezolute Inc |
2 Q |
- |
- |
- |
-38.51% |
| Sage Therapeutics Inc |
2 Q |
91.71% |
-6480.4% |
-3438.88% |
-49.82% |
| Cassava Sciences Inc |
2 Q |
- |
- |
- |
-44.48% |
| Strongbridge Biopharma plc |
2 Q |
95.35% |
-131.86% |
-100.82% |
-66.82% |
| Sunshine Biopharma Inc |
2 Q |
35.12% |
-16.22% |
0.37% |
-94.77% |
| Scpharmaceuticals Inc |
2 Q |
78.39% |
-864.1% |
-250.49% |
-73.77% |
| Scopus Biopharma Inc |
2 Q |
- |
- |
- |
- |
| Societal Cdmo Inc |
2 Q |
20.51% |
-14.73% |
-7.29% |
-39.72% |
| Scynexis Inc |
2 Q |
- |
93.01% |
23.87% |
212.29% |
| Schrodinger Inc |
2 Q |
39.25% |
12.16% |
- |
12.56% |
| Seelos Therapeutics inc |
2 Q |
- |
-7039.62% |
-1960.86% |
- |
| Selecta Biosciences Inc |
2 Q |
- |
-216.94% |
-238.54% |
-43.98% |
| Sangui Biotech International Inc |
1 Q |
- |
-205.74% |
-12.47% |
- |
| Sagimet Biosciences inc |
2 Q |
- |
- |
- |
- |
| Sigilon Therapeutics Inc |
2 Q |
- |
-127.22% |
-366.66% |
-83.83% |
| Shuttle Pharmaceuticals Holdings Inc |
2 Q |
- |
- |
- |
-81.04% |
| Siga Technologies Inc |
2 Q |
83.42% |
-48.92% |
-671.42% |
18.07% |
| Sio Gene Therapies Inc |
4 Q |
- |
- |
- |
-55.94% |
| Skinvisible Inc |
2 Q |
- |
-5521.5% |
-511.8% |
- |
| Skye Bioscience Inc |
2 Q |
- |
- |
- |
- |
| Sol gel Technologies Ltd |
4 Q |
- |
10.3% |
41.45% |
5.79% |
| Silence Therapeutics Plc |
4 Q |
39.94% |
-317.44% |
- |
-462.23% |
| Acelyrin Inc |
1 Q |
- |
- |
- |
- |
| Salarius Pharmaceuticals inc |
2 Q |
- |
- |
- |
-292.88% |
| Sellas Life Sciences Group Inc |
2 Q |
- |
- |
- |
-406.99% |
| Summit Therapeutics Inc |
2 Q |
- |
- |
- |
-466.06% |
| Syndax Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-39.08% |
| Soligenix inc |
2 Q |
11.07% |
-779.02% |
- |
-7335.81% |
| Sonoma Pharmaceuticals Inc |
2 Q |
35.13% |
-41.38% |
-8.05% |
-81.76% |
| Synaptogenix Inc |
2 Q |
- |
- |
- |
40.31% |
| Sensei Biotherapeutics Inc |
2 Q |
- |
- |
- |
-46.2% |
| Sanofi |
4 Q |
69.83% |
18.69% |
22.25% |
11.29% |
| Sonnet Biotherapeutics Holdings Inc |
2 Q |
- |
-10710.29% |
-11856.46% |
-4385.1% |
| Spectrum Pharmaceuticals Inc |
1 Q |
93.19% |
-32.07% |
76.88% |
-209.59% |
| Spruce Biosciences Inc |
2 Q |
- |
-592.33% |
- |
-54.8% |
| Scisparc Ltd |
4 Q |
76.1% |
- |
- |
40.19% |
| Spero Therapeutics Inc |
2 Q |
- |
-438.66% |
-683.51% |
-17.69% |
| Ars Pharmaceuticals Inc |
2 Q |
- |
-173700% |
- |
-8.75% |
| Sarepta Therapeutics Inc |
2 Q |
- |
-9.16% |
-7.56% |
-159.95% |
| Sierra Oncology Inc |
1 Q |
- |
- |
- |
-76.49% |
| Statera Biopharma Inc fka Cytocom Inc |
3 Q |
74.74% |
-500.68% |
0% |
- |
| Stoke Therapeutics Inc |
2 Q |
- |
- |
- |
-52.95% |
| Satsuma Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-115.24% |
| Shattuck Labs Inc |
2 Q |
- |
-10673% |
- |
-54.86% |
| Supernus Pharmaceuticals inc |
2 Q |
84.44% |
-0.61% |
-322.72% |
4.86% |
| Sunwin Stevia International Inc. |
2 Q |
14.99% |
-2.52% |
8.06% |
-106.36% |
| Sinovac Biotech Ltd |
4 Q |
54.15% |
5.9% |
- |
0.69% |
| Savara Inc |
2 Q |
- |
- |
- |
-41.62% |
| 60 Degrees Pharmaceuticals Inc |
2 Q |
-209.04% |
-5616.46% |
-412.88% |
- |
| Synlogic Inc |
2 Q |
- |
-42994.29% |
- |
-85.18% |
| Syros Pharmaceuticals Inc |
2 Q |
- |
-1279.84% |
- |
-87.04% |
| Takeda Pharmaceutical Company Limited |
1 Q |
69.11% |
7.87% |
20.57% |
4.99% |
| Taro Pharmaceutical Industries Ltd |
1 Q |
46.83% |
4.44% |
16.03% |
1.47% |
| Theravance Biopharma inc |
2 Q |
- |
-113.79% |
-596.91% |
220.85% |
| Tricida Inc |
3 Q |
- |
- |
- |
- |
| Alaunos Therapeutics Inc |
2 Q |
- |
-219325% |
-477925% |
-120.93% |
| Tenax Therapeutics Inc |
2 Q |
- |
- |
- |
96.87% |
| Terns Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-28.19% |
| Teva Pharmaceutical Industries Limited |
2 Q |
46.31% |
-23.16% |
29.71% |
-27% |
| Tff Pharmaceuticals Inc |
2 Q |
- |
-1505.98% |
-1365.94% |
-153.67% |
| Tg Therapeutics inc |
2 Q |
- |
-296.19% |
- |
-309.59% |
| Third Harmonic Bio Inc |
2 Q |
- |
- |
- |
5.8% |
| Thorne Healthtech Inc |
2 Q |
55.89% |
5.96% |
0.87% |
13.58% |
| Theseus Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-25.55% |
| Teligent Inc |
2 Q |
-25.91% |
-123.32% |
-47.14% |
- |
| Tiziana Life Sciences Ltd |
4 Q |
- |
- |
- |
-78.67% |
| Timber Pharmaceuticals Inc |
2 Q |
- |
-29367.95% |
-19196.18% |
-516.88% |
| Tango Therapeutics Inc |
2 Q |
- |
-141.87% |
60.28% |
-44.38% |
| Tonix Pharmaceuticals Holding Corp |
1 Q |
- |
- |
- |
-48.46% |
| Theriva Biologics inc |
1 Q |
- |
- |
- |
-31.89% |
| Tempest Therapeutics Inc |
2 Q |
- |
- |
- |
-218.64% |
| Turning Point Therapeutics Inc. |
2 Q |
- |
-103435.29% |
-16289.92% |
-37.45% |
| Entrada Therapeutics Inc |
2 Q |
- |
-76.21% |
-814.01% |
-30.45% |
| Trillium Therapeutics Inc |
3 Q |
- |
- |
- |
15.79% |
| Trevi Therapeutics Inc |
2 Q |
- |
- |
- |
-26.38% |
| Trevena inc |
2 Q |
97.09% |
-265.21% |
-25.39% |
-265.73% |
| 2seventy Bio Inc |
2 Q |
97.48% |
-116.76% |
-270.24% |
-51.38% |
| Travere Therapeutics Inc |
2 Q |
96.67% |
-143.44% |
-151.6% |
-273.8% |
| Therapeuticsmd Inc |
2 Q |
- |
-552.4% |
-805.26% |
341.13% |
| Neuropathix Inc. |
1 Q |
- |
-767.19% |
41.6% |
- |
| Tyme Technologies Inc. |
2 Q |
- |
- |
- |
-29.11% |
| Tyra Biosciences Inc |
2 Q |
- |
- |
- |
-19.96% |
| Unity Biotechnology Inc |
2 Q |
- |
- |
- |
-76.08% |
| Unicycive Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Universe Pharmaceuticals Inc |
3 Q |
54.53% |
-21.76% |
-5.9% |
-18.81% |
| Urogen Pharma Ltd |
2 Q |
90.34% |
-116.62% |
-79.3% |
- |
| United Therapeutics Corporation |
2 Q |
89.25% |
43.45% |
-16.13% |
17.52% |
| Vaccitech Plc |
2 Q |
- |
-7132.93% |
-5478.44% |
-23.44% |
| Avricore Health Inc |
4 Q |
25.83% |
-46.27% |
17.12% |
-41.66% |
| Vaxxinity Inc |
2 Q |
- |
- |
- |
-129% |
| Vbi Vaccines Inc |
2 Q |
- |
-6198.33% |
-2715.56% |
-235.41% |
| Vascular Biogenics Ltd |
2 Q |
- |
- |
- |
234.43% |
| Vaccinex Inc |
2 Q |
- |
- |
- |
0% |
| Vera Therapeutics Inc |
2 Q |
- |
- |
- |
-89.3% |
| Veru Inc |
2 Q |
38.09% |
- |
-225.51% |
-243.8% |
| Verve Therapeutics Inc |
2 Q |
- |
-2579.22% |
-654.75% |
-37.08% |
| Viveon Health Acquisition Corp |
4 Q |
- |
- |
- |
- |
| Vincerx Pharma Inc |
2 Q |
- |
- |
- |
-134.99% |
| Virios Therapeutics inc |
1 Q |
- |
- |
- |
-36.07% |
| Viracta Therapeutics Inc |
2 Q |
- |
- |
- |
-133.85% |
| Viking Therapeutics Inc |
2 Q |
- |
- |
- |
-36.28% |
| Vanda Pharmaceuticals Inc |
2 Q |
92.4% |
3.3% |
-443.24% |
2.81% |
| Verrica Pharmaceuticals Inc |
2 Q |
- |
-6038.46% |
-2643.96% |
-45.7% |
| Verona Pharma Plc |
2 Q |
- |
- |
- |
-20.3% |
| Virpax Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-96.12% |
| Vertex Pharmaceuticals Inc |
2 Q |
87.62% |
36.73% |
34.41% |
23.68% |
| Verastem Inc |
2 Q |
- |
- |
- |
-122.33% |
| Vistagen Therapeutics Inc |
2 Q |
- |
- |
- |
-268.03% |
| Viatris Inc |
2 Q |
41.05% |
6.74% |
3.08% |
9.04% |
| Vtv Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Ventyx Biosciences Inc |
2 Q |
- |
- |
- |
-43.95% |
| Vyne Therapeutics Inc |
2 Q |
- |
-7450.37% |
-7095.56% |
-122.06% |
| Wellness Center Usa Inc |
2 Q |
90.33% |
-689.92% |
-20.87% |
- |
| Wave Life Sciences Ltd |
2 Q |
- |
-95.47% |
-160.95% |
- |
| Xenetic Biosciences Inc |
2 Q |
- |
-161.44% |
-194.95% |
-31.71% |
| Xbiotech Inc |
2 Q |
- |
- |
- |
-11.95% |
| Exicure Inc |
2 Q |
- |
- |
- |
34.49% |
| Xenon Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-23.3% |
| Xeris Biopharma Holdings Inc |
1 Q |
83.98% |
-101.42% |
-213.83% |
-63.96% |
| Xilio Therapeutics inc |
2 Q |
- |
- |
- |
-87.74% |
| Xencor Inc |
2 Q |
- |
-48.23% |
-82.78% |
-18.13% |
| Xoma Corporation |
2 Q |
- |
-325.69% |
-775.33% |
-25.75% |
| Xortx Therapeutics Inc |
4 Q |
- |
-697.75% |
72.33% |
-9.87% |
| Novaccess Global Inc |
1 Q |
- |
- |
- |
- |
| Xtl Biopharmaceuticals Ltd |
4 Q |
- |
- |
- |
-19.55% |
| Y mabs Therapeutics inc |
1 Q |
82.54% |
-267.67% |
-236.89% |
-59.67% |
| Ys Biopharma Co Ltd |
1 Q |
77.68% |
-21.17% |
0% |
-19.97% |
| Zealand Pharma A |
4 Q |
59.39% |
-348.01% |
- |
-109.74% |
| Zogenix Inc |
4 Q |
93.83% |
- |
-18.63% |
-91.2% |
| Zai Lab Limited |
2 Q |
65.49% |
-175.56% |
-28.9% |
-38.48% |
| Zentalis Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-70.83% |
| Zomedica Corp |
2 Q |
80.19% |
-103.98% |
- |
-7.34% |
| Zosano Pharma Corporation |
1 Q |
34.85% |
-25309.85% |
- |
-172.07% |
| Zoetis Inc |
2 Q |
72.16% |
30.73% |
-17.98% |
48.61% |
| Zevra Therapeutics Inc |
2 Q |
92.01% |
-60.02% |
- |
-40.67% |
| Zyversa Therapeutics Inc |
2 Q |
- |
- |
- |
0% |
| Zymeworks Inc |
2 Q |
- |
-730.53% |
-563.88% |
46.66% |
| Zynerba Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-90.03% |
